ABLATE: a score to predict complications and recurrence rate in percutaneous treatments of renal lesions
Sign Up to like & getrecommendations! Published in 2020 at "Medical Oncology"
DOI: 10.1007/s12032-020-01351-3
Abstract: RENAL score has been validated on predicting adverse events and relapses in percutaneous treatments of renal lesions. To better fit interventional issues a modified score (mRENAL) has been introduced, but the only difference from the… read more here.
Keywords: renal lesions; treatments renal; renal mrenal; ablate score ... See more keywords